CGM Continuous Blood Glucose Monitoring System Sensor CT3
- Point of origin
- China CE ISO13485 ISO9001 MDR
- Throughput
- 3 minutes to calculate a blood glucose value
- Application scenarios
- family Clinic
The CGM Continuous Blood Glucose Monitoring System Sensor CT3 is designed to enhance diabetes management through its advanced features, user-friendly design, and reliable performance.
Performance Advantages:
Calibration-free
1-hour initialization
Display values in real-time
9.07% MARD accuracy
14 days to wear
IP58 waterproof and dustproof
real-time data sharing
Sensor validity period: 12 months
3 minutes to calculate a blood glucose value
High and low blood glucose alarm/severe low blood glucose alarm (less than 3.1)
Measurement range 1.7-27.8mmol/L
No finger pricks
No scanning
Comfortable to wear for 14 days
Customizable Alerts and Alarm
7 glucose trend arrows
4 options for glucose timeline
Statistics and Daily Reports can be outputted
Share real-time data with up to 20 people
Allow logging of meals, exercise, and insulin
Real-time High and Low alerts to take action
Can help reduce HbA1C
Can help reduce Hypoglycemic Events
Auto-applicator & sensor
The simple auto-applicator is a one-touch applicator that easily inserts a small built-in sensor just beneath the skin.
Transmitter (2-year lifetime)
The rechargeable transmitter can be used for up to two years. It will support 14 days' wearing on a single charge.
Wired Charging Stand
The fast charge only needs less than 1.5 hours for one time.
480 continuous readings per day are sent to your phone via bluetooth.
Reliable
With 9.07% overall MARD for adults, Anytime CT3 is reliable and protective for people who want to improve glucose management.
MARD (Mean Absolute Relative Difference) is a metric used to evaluate the accuracy of continuous glucose monitoring (CGM) systems.
It measures the difference between the glucose values reported by the CGM system and the reference glucose values obtained from a laboratory blood glucose measurement.
A lower MARD value indicates better accuracy of the CGM system.
The MARD value of CGM varies depending on the specific device and the study conducted to evaluate its accuracy.
APP
Glooko is the world’s leading Unified Platform for Diabetes Management, allowing personal users and professionals to have a clear and structured way through graphs, tables and statistics.
Patients can:Enter and view diabetes data in one location to better understand what’s affecting their glucose levels
Sync data from CT3Log meals and activity – The food database has over 500,000 items, and Glooko is compatible with popular fitness trackers like Fitbit and Strava
View educational resources and best practices about diabetes
Professionals can:
Manage your diabetes population for 24/7 care
View and analyze diabetes data that has been synced remotely by patients or uploaded during a clinic visit
Find and group targeted patients with search and filter capabilities
Efficiently analyze and provide guidance to patient groups
Improve workflow efficiency and increase your patient load
Smart appearance
Flexible probe shortened by 33%
20% smaller size
Thinner and smaller body, light and convenient to wear.